English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

survival to immuno-cell herapy without antecedent surgery for advanced cancers Goki Shindo*1, Takayoshi Endo1, Masamitsu Onda1, Yoju Miyamoto2, Toru Kaneko3, Shigenori Goto4 1Meditopia Numazu Clinic, 575-1 Okaisshiki, Numazu city, Shizuoka 410-0012, Japan 2Shinyamanote Hospital, 3-6-1 Suwa-cho Higashimatsuyama city, Tokyo 189-0021 Japan 3Odaiba Nijihashi Clinic, Daiba clinic mall 2F, 2-2-4 Daiba Minato-Ku, Tokyo 135-0091 Japan 4Seta Clinic Tokyo, New Surugadai Bldg. 4F, 2-1-45 Kanda Surugadai, Chiyoda-Ku, Tokyo 101-0062, Japan *Corresponding Author: Goki Shindo M.D., Meditopia Numazu Clinic, 575-1 Okaisshiki, Numazu city, Shizuoka 410-0012, Japan,Tel: +81-55-923-6600; Facsimile number: +81-55-923-6606; E-mail: gshindo@meditopia.or.jp

japan journal of medicine

Adoptive immuno-cell therapy with antecedent surgery has superior actuarial survival to immuno-cell herapy without antecedent surgery for advanced cancers